Archive for the ‘Treatment’ Category

Devastation of CARES Act & Media Propaganda Exposed. Former Media Exec States UK Warned Media Not to Challenge Official COVID Narrative. Current Lawsuit Against Biden Admin

https://rumble.com/vyuseu-heroes-taking-down-evil-journalist-april-moss-goes-nuclear-exposes-vaxx-hos.

The CARES Act Literally Hand-Cuffs Doctors From Doing Their Jobs

Media outlets mass-produce propaganda to control society, silencing those who dare to disrupt their narratives. Award winning journalist and ex-CBS Detroit employee, April Moss joined the Stew Peters Show Monday to expose Big Tech and Big Pharma’s collusion to kill the unvaccinated, the compliance of the media, nurses, doctors, and more.

Moss’s upcoming documentary, ‘Bad Medicine’ exposes how the media is killing thousands with the help Big Pharma, and the damage done so far. Visit FreedomMed.org to find clinics and doctors near you that prescribe ivermectin and effective treatments against the plandemic.

For appropriate COVID treatment:

For more:

Creating a “National Pandemic Emergency” provided justification for such sweeping actions that override individual physician medical decision-making and patients’ rights.

The CARES Act provides incentives for hospitals to use treatments dictated solely by the federal government under the auspices of the NIH. These “bounties” must paid back if not “earned” by making the COVID-19 diagnosis and following the COVID-19 protocol.  Government employees making the rules happen to have patents on nearly every aspect of COVID including the FDA approved treatments.

___________________

https://thehighwire.com/videos/tv-exec-reveals-shocking-censorship-of-media/  Video Here (Approx. 17 Min)

Former British broadcasting executive, Mark Sharman, recently spoke out about the incredible failures of the media during Covid. Journalists were warned not to question the official government line in their reporting.

https://thenewamerican.com/u-k-warned-media-not-to-challenge-official-covid-narrative-says-former-media-exec

U.K. Warned Media Not to Challenge Official Covid Narrative, Says Former Media Exec

U.K. Warned Media Not to Challenge Official Covid Narrative, Says Former Media Exec
RistoArnaudov/iStock/Getty Images Plus

During the beginning stages of the Covid-19 pandemic, the British government threatened the media with penalties for reporting anything other than the official line, turning journalists into “cheerleaders for the government,” a former U.K. news executive said last week.

Mark Sharman, a former executive at ITV News and Sky News, told GB News that the U.K.’s Office of Communications (Ofcom) issued a bulletin to broadcasters in early 2020.

“It was a warning to basically say, ‘Do not question the official government line [on Covid-19],’” he said.

“Now, to be fair to them,” he continued, “they said, ‘You can have opposition voices on, but presenters must intervene if there’s any danger of harmful misinformation.’”

That, of course, means anything that contradicts the official narrative, no matter how rooted in evidence or how reliable its source may be.

Ofcom meant what it said. The agency is empowered to impose a variety of sanctions on broadcasters that violate its dictates, up to and including revoking a broadcaster’s license, and it has done so repeatedly over the last two years. However, as Sharman pointed out, most of the penalties were meted out to smaller outlets that couldn’t fight back.  (See link for article)

__________________

Please go here to learn of how our government pays the media directly, puts “informants” in the national media and other institutions, uses reporters for information, and plants news stories.

SUMMARY:

  • Exec admits the current media environment has caused the biggest assault on freedom of speech and democracy he’s known in his lifetime.
  • The UK is far from alone.  There is a worldwide narrative and anyone dissenting is censored, branded as giving “false” or “misinformation,” and called “conspiracy theorists”.
  • The exec also admitted that “vaccine” injuries are not being covered in the media.
  • He states the “vaccine” damaged suffer twice from the actual injury but then again by doctors who don’t accept their plight.
  • He states the media has let the public down for not holding the government accountable – particularly over the injections, as well as not asking questions about the government doing secret deals with Pfizer, the FDA wanting to hide Pfizer’s data for 75 years, the government spending 500 million pounds on COVID shot advertising, as well as the fact the world’s biggest companies are owned by BlackRock & Vanguardsubsidized by the Gates Foundation and which in turn owns about 35 billion pounds worth of Pfizer stock.
  • The Big Tech/Big Media approach to COVID has now set a precedent that will be with us for years to come due to one-sided coverage, censorship, and cancel-culture tactics.
Only a few media outlets have apologized over their biased, singular coverage and they are both foreign:

___________________

https://thenewamerican.com/lawsuit-biden-admin-pressuring-big-tech-to-censor-users/

Lawsuit: Biden Admin Pressuring Big Tech to Censor Users

Lawsuit: Biden Admin Pressuring Big Tech to Censor Users
tylim/iStock/Getty Images Plus

The U.S. Surgeon General and the Department of Health and Human Services (HHS) of the Biden administration have directed social-media platforms, including Twitter, to suppress alleged “misinformation” about Covid, alleges a federal lawsuit filed on March 24.

The New Civil Liberties Alliance (NCLA), a conservative civil-rights group, filed the lawsuit in an Ohio federal court on behalf of social-media users Mark Changizi, Daniel Kotzin, and Michael Senger.

According to the lawsuit, all three garnered “tens of thousands of followers” on Twitter and other social-media platforms by actively criticizing restrictions imposed by governments and public-health authorities in response to Covid. As a result, the three have been unlawfully censored. (See link for article)

SUMMARY:

  • A “coordinated and escalating public campaign” on censorship started when White House Press Secretary Jen Psaki announced the president believes social media platforms have a responsibility to “stop amplifying untrustworthy content, disinformation, and misinformation,” regarding COVID, the injections, and elections.  DHS went so far as to brand dissenters as “terrorists.”
  • Pressure amplified in July when Surgeon General Vivek Murthy and HHS started “ordering” social media companies to remove certain posts and ban the perps of “misinformation.” Please see Murthy and Woodcock’s conflicts of interest.
  • The lawsuit contains detailed quotes from admin officials showing they contemplated penalties against social media platforms that allowed “misinformation.”
  • Plaintiffs were suspended and punished from Twitter for simply tweeting that COVID shots don’t stop transmission and that masks don’t work and can be harmful (all of which is true).
  • On March 3, 2022 Murthy went further by demanding tech platforms turn over “information about sources of COVID ‘misinformation’ by May, 2022.
  • Plaintiffs state that no statute endows the Surgeon General with the authority to direct social media companies to censor individuals or viewpoints. Murthy is either misconstruing or violating statutes and articles of the Constitution.
  • Plaintiffs state the administration is not simply colluding but instrumentalizing tech platforms to silence differing opinions which violates free speech.
  • The administration also likely violates the 4th amendment by demanding platforms turn over info about users to the government that the government deems problematic.
  • Murthy’s and HHS’s actions likely exceed their powers under APA and the directives should be found unlawful and invalid.
  • Twitter, Facebook and Youtube have all announced bans on “false claims” about COVID-related matters that go against claims from public health “experts” who just happen to be on a government payroll and own patents on virtually every aspect of COVID.  Youtube’s parent company Google, is directly invested in the AstraZeneca/Oxford COVID “vaccine,” and is also partnered directly with the U.S. military’s DARPA program.

Interestingly, a study has shown that Big Tech censorship of “extremism” actually increases radicalization.

University of Kentucky Study to Explore Why Lyme Disease Symptoms Persist For Some

http://uknow.uky.edu/research/uk-study-explore-why-lyme-disease-symptoms-persist-some

UK Study to Explore Why Lyme Disease Symptoms Persist for Some

LEXINGTON, Ky. (March 4, 2022) — Although most cases of Lyme disease can be cured with a two-to-four-week course of antibiotics, some patients still experience lingering, debilitating effects of the disease months after they finish treatment.

Researchers in the University of Kentucky’s College of Medicine are seeking to understand if the antibiotic regimen used to treat Lyme disease could also be contributing to Post-Treatment Lyme Disease Syndrome (PTLDS), which includes ongoing symptoms of pain, fatigue or difficulty thinking.

Antibiotics can cause imbalances to the gut microbiome, the trillions of microbes essential to health and immune system function. Known as dysbiosis, these disruptions are linked to various autoimmune and inflammatory diseases, as well as cardiovascular disease and depression.

The study, supported by the Global Lyme Alliance and co-led by Ilhem Messaoudi, Ph.D., and Brian Stevenson, Ph.D., in the Department of Microbiology, Immunology and Molecular Genetics, will be the first to assess the role of dysbiosis in the development of PTLDS.

Lyme disease is a tick-borne illness caused by the bacteria Borrelia burgdorferi. The Centers for Disease Control and Prevention estimates that 476,000 Americans are diagnosed with Lyme disease each year.

The research will provide new insights into the interaction between B. burgdorferi infection, antibiotics, and the gut microbiome that may lead to more effective ways to treat Lyme disease, says Messaoudi.

“Lyme disease can be just an acute episode, but for some people, it becomes a prolonged disease with a lot of complications and scientists don’t fully understand where these complications come from,” Messaoudi said. “This study may provide targets that could lead to the development of new antibiotic treatment plans that address the microbiome as well as the immune system.”

Messaoudi and Stevenson will be collaborating with researchers at the Oregon National Primate Research Center to carry out an in-depth analysis of host responses. The research will also establish an ideal animal model for future studies on the cognitive and physical effects of PTLDS.

The University of Kentucky is increasingly the first choice for students, faculty and staff to pursue their passions and their professional goals. In the last two years, Forbes has named UK among the best employers for diversity, and INSIGHT into Diversity recognized us as a Diversity Champion four years running. UK is ranked among the top 30 campuses in the nation for LGBTQ* inclusion and safety. UK has been judged a “Great College to Work for” three years in a row, and UK is among only 22 universities in the country on Forbes’ list of “America’s Best Employers.”  We are ranked among the top 10 percent of public institutions for research expenditures — a tangible symbol of our breadth and depth as a university focused on discovery that changes lives and communities. And our patients know and appreciate the fact that UK HealthCare has been named the state’s top hospital for five straight years. Accolades and honors are great. But they are more important for what they represent: the idea that creating a community of belonging and commitment to excellence is how we honor our mission to be not simply the University of Kentucky, but the University for Kentucky.

For more:

Borrelia Miyamotoi Found in 3-5% of New England Blood Samples = Tens of Thousands Possibly Infected

https://www.futurity.org/borrelia-miyamotoi-new-england-ticks-2716322-2/

Another tick bacteria turns up in New England blood samples

Human blood samples from across New England show evidence of Borrelia miyamotoi, a relative of the bacteria that causes Lyme disease.

The findings add important new details to understanding the bacteria species, Borrelia miyamotoi, which was only recently found to infect humans. The tiny species is transmitted by the same deer ticks that carry the Lyme disease pathogen, and can cause meningoencephalitis and relapsing fevers.

“We thought that Borrelia miyamotoi, because it was so recently discovered, would have been more locally confined,” says Peter Krause, senior research scientist at the Yale School of Public Health and senior author of the study. “To our surprise, it was found at all our testing sites throughout New England.”

Krause and Durland Fish, professor emeritus of epidemiology (microbial diseases), were part of a team of researchers who first discovered Borrelia miyamotoi’s ability to infect humans in 2011. Graduate student researcher Demerise Johnston is first author of the new study in the journal Clinical Infectious Diseases.

By testing more than 1,100 blood samples gathered from states across New England in 2018, the team of researchers discovered that almost 3% of the study subjects showed evidence of an immune response (antibody) to Borrelia miyamotoi, with some collection sites demonstrating as much as 5%. These samples were so geographically dispersed in New England that the researchers were unable to determine whether the origin of the infection was southeastern New England, as is the case for Lyme disease and babesiosis, another tick-borne infection.

The proportion of samples containing Borrelia miyamotoi antibody was low compared to that of Lyme disease pathogen, which reached more than 15% in some areas. But Krause says the level of Borrelia miyamotoi antibodies found in the samples indicates that physicians should keep an eye out for the bacteria in patients who present with Lyme disease-like symptoms.

“We’re talking about the possibility of tens of thousands of New England residents becoming infected with Borrelia miyamotoi based on what we found,” he says. “I think it’s important for people to realize that this disease is out there.”

For the study, the researchers also looked into the prevalence of another microorganism, Babesia microti, in their samples. That species is the primary cause of human babesiosis, and it can be spread through ticks just like the other two. Their analysis suggested that around 10% of the samples showed evidence of antibodies against this pathogen. These infections can be transmitted at the same time and coinfection is possible.

“Still, Lyme predominates, but the gap is not as great as is assumed,” Krause says. “There’s more Babesia infections than people realize. Physicians working in areas where babesiosis occurs should be aware of the disease and test for it when patients have consistent symptoms.”

Borrelia miyamotoi disease is much less frequent than those for the microbial species that cause Lyme disease and babesiosis. Krause says there are dependable treatment strategies that can cure individuals who have Borrelia miyamotoi infection. Those strategies involve essentially the same antibiotic treatments that treat Lyme disease. He and his colleagues say in the study that tracking the geographic spread of the species could help health care workers be on alert for potential transmission through ticks and possibly through blood transfusions, although additional studies are needed to confirm that this could happen.

Coauthors are from the Laboratory of Emerging Pathogens at the US Food and Drug Administration and L2 Diagnostics in New Haven, Connecticut.

Source: Matt Kristofferson for Yale University

Naltrexone for Long COVID

https://www.theepochtimes.com/how-a-drug-for-opioid-and-alcohol-addiction-is-helping-treat-long-covid

How a Drug for Opioid and Alcohol Addiction Is Helping Treat Long COVID

By Meiling Lee
March 26, 2022 Updated: March 26, 2022

A drug that’s helping millions of people with opioid or alcohol dependence is also being used to treat those suffering symptoms of long COVID.

Naltrexone has been around since 1984 to treat opioid or alcohol addiction. Given in high doses of 50-milligram tablets or a 380-milligram intramuscular injection, the drug works by binding to opioid receptors in the brain to block the effects—especially the urges and cravings to use—of opioids and alcohol.

Naltrexone has also been found to treat other disorders when administered in low doses. It is used off-label to treat obesity, nerve pain, anxiety, and autoimmune disorders.

“I found it very effective in my patients with rheumatoid arthritis, with Crohn’s disease, with other autoimmune processes, and chronic fatigue syndrome,” Dr. Keith Berkowitz, an internist, told The Epoch Times.

Naltrexone is given at doses of 0.5 to 4.5 milligram for patients with long COVID, along with other repurposed medications like prednisone, ivermectin, and vitamin D, according to Berkowitz. At low doses, naltrexone has a potent anti-inflammatory effect, as well as an endorphin effect. (See link for article)

___________________

SUMMARY:
  • The addition of naltrexone to FLCCC’s treatment protocol has been a “game-changer” for patients struggling with long COVID-19
  • One doctor states patients with long COVID aren’t believed by other doctors for it.
  • WHO published a clinical case definition of long COVID as symptoms that occur 3 months from onset of COVID-19 with symptoms and that last for at least 2 months and cannot be explained by an alternative diagnosis.
  • The CDC defines long COVID as a “wide range of new, returning, or ongoing health problems people can experience four or more weeks after first being infected” with SARS-CoV-2.
  • FLCCC and other experts recognize long COVID can happen not only after infection but after a COVID shot.
  • It is believed prolonged exposure to spike proteins and lipid nanoparticles produces chronic inflammation causing long COVID. Circulation Research demonstrated the spike protein was able to damage the cells of the vascular system, and that COVID-19 is a vascular disease rather than a respiratory illness.
  • Another study (pdf)—waiting to be peer-reviewed found that people who received “two doses of COVID-19 shots had higher odds of developing Long COVID.”
  • Another study found that the spike protein from the shots persis in the body & remains in lymph node germinal centers for 60 days after the second dose of an mRNA shot.
  • On expert states the more exposure an individual has to the spike protein, the more symptoms they will likely experience.
  • Brain fog is a long COVID symptom that can be so debilitating patients aren’t able to work.
  • Cognitive dysfunction, another long COVID symptom is one of the most frequent persistent symptoms reported, & occurs in 70 percent of long COVID patients. Brain fog, memory issues, and speech and language problems occurred more often at eight weeks or later than during initial infection, and about 86% of participants reported being unable to work due to cognitive dysfunction and/or memory loss, according to a study.
  • Interleukin 6 (IL-6) causes damage … and low dose naltrexone helps modulate it and nuclear factor kappa B protein, or the inflammatory pathway, Dr. Mobeen Syed said in a video presentation on naltrexone.
Naltrexone is often used with Lyme/MSIDS patients as well.  For more:

Kill Babesia: Treatment Guide Update

Before reading Dr. Ross’ Babesia treatment update, please see:  https://madisonarealymesupportgroup.com/2016/01/16/babesia-treatment/

**UPDATE, 3/14/22**

Babesia Treatment Update, Dr. Ross

https://www.treatlyme.net/guide/kills-babesia-a-brief-guide

The main update I can see is his focus on “Babesia Nests” and a blood clotting protein called fibrin which limit blood flow to tissues and may inhibit antimicrobials as well as the immune system.  He uses:

  • Lumbrokinase which he claims is strongest
  • nattokinase
  • serapeptase

Also in this update he addresses Babesia microti specifically and that tafenoquine, a newer anti-malaria medication approved in 2018 has good effects against in the lab and in a recent case report.

He also states that research on those who have Babesia WITH Lyme is nonexistent but that LLMD’s state it can take four to five months of continuous antimicrobials for Babesia to resolve.  Dr. Horowitz is on record stating it takes 9-12 months for resolution.  Most LLMD’s treat Babesia for 3 weeks on and one week off treatment.

__________________

**Comment**

On a personal note, my husband and I treated Babesia for an entire year with success.  Our treatment is laid out in the top link.  My husband suffered with severe blood coagulation (the fibrin issue Dr. Ross calls “Babesia nests”) that was successfully treated with heparin, a blood thinner.  I have also heard from numerous other patients that this miraculously helped them as well.  If you have tried the suggested enzymes and they are not strong enough or cost is an issue, please discuss heparin with your LLMD.